Position in RGNX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,508,400
-$507,600 QoQ
Shares Held
180,000
+28.6% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $534,286,565 across 150 Biotechnology names. RGNX ranks #52 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
974,776 | $55,065,096 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,190,416 | $47,890,435 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,001 | $24,725,252 | |
| 4 | BNTX |
BioNTech SE
|
275,000 | $24,442,000 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
295,100 | $22,159,059 | |
| 6 | ARGX |
Argenx SE
|
30,000 | $21,907,500 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,000 | $20,094,300 | |
| 8 | IMCR |
Immunocore Holdings plc
|
633,174 | $19,090,196 |
All Filings in RGNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,508,400 | 180,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,016,000 | 140,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,930,000 | 200,000 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $1,806,200 | 220,000 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $2,109,250 | 295,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,381,613 | 308,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,255,350 | 215,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,930,500 | 165,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $946,043 | 44,900 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,615,500 | 90,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,892,900 | 115,000 | Shares | Sole | 2023-12-07 | |
| 2023-06-30 | $1,699,150 | 85,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,149,728 | 60,800 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,020,600 | 45,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $528,600 | 20,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,729,000 | 70,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,157,350 | 65,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,125,500 | 65,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,096,000 | 50,000 | Shares | Sole | 2021-12-29 | |
| 2021-06-30 | $3,010,875 | 77,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,573,835 | 46,140 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,814,400 | 40,000 | Shares | Sole | 2021-03-04 | |
| 2020-09-30 | $7,237,760 | 263,000 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,102,600 | 220,000 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,047,500 | 125,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||